142 related articles for article (PubMed ID: 36265362)
21. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A
J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
[TBL] [Abstract][Full Text] [Related]
22. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status.
Xie JC; Yang S; Liu XY; Zhao YX
Cancer Med; 2018 Aug; 7(8):3722-3742. PubMed ID: 30009575
[TBL] [Abstract][Full Text] [Related]
23. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
Kimple RJ; Grabowski S; Papez M; Collichio F; Ewend MG; Morris DE
Am J Clin Oncol; 2010 Jun; 33(3):265-70. PubMed ID: 19823072
[TBL] [Abstract][Full Text] [Related]
24. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
Ryu JY; Min KL; Chang MJ
PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study.
Yang K; Ma Y; Chen G; Zeng S; Guo T; Yang Z
Radiat Oncol; 2022 Oct; 17(1):174. PubMed ID: 36307810
[TBL] [Abstract][Full Text] [Related]
27. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma.
Barnholtz-Sloan JS; Williams VL; Maldonado JL; Shahani D; Stockwell HG; Chamberlain M; Sloan AE
J Neurosurg; 2008 Apr; 108(4):642-8. PubMed ID: 18377240
[TBL] [Abstract][Full Text] [Related]
28. Distinct survival and clinical profile of infantile glioblastoma: insights from a national database.
Lu VM; Eichberg DG; Luther EM; Shah AH; Daniels DJ; Maher OM; Niazi TN
Childs Nerv Syst; 2022 Jan; 38(1):85-94. PubMed ID: 34643775
[TBL] [Abstract][Full Text] [Related]
29. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.
Huang J; Samson P; Perkins SM; Ansstas G; Chheda MG; DeWees TA; Tsien CI; Robinson CG; Campian JL
J Neurooncol; 2017 Feb; 131(3):593-601. PubMed ID: 27844308
[TBL] [Abstract][Full Text] [Related]
30. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
Guckenberger M; Mayer M; Buttmann M; Vince GH; Sweeney RA; Flentje M
Strahlenther Onkol; 2011 Sep; 187(9):548-54. PubMed ID: 21858417
[TBL] [Abstract][Full Text] [Related]
31. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
Bingham B; Patel CG; Shinohara ET; Attia A
J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
[TBL] [Abstract][Full Text] [Related]
32. Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma.
Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
Neurol India; 2014; 62(1):42-7. PubMed ID: 24608453
[TBL] [Abstract][Full Text] [Related]
33. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
34. Effect of valproic acid on the outcome of glioblastoma multiforme.
Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
[TBL] [Abstract][Full Text] [Related]
35. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
36. National Trends for Reoperation in Older Patients with Glioblastoma.
Chen YR; Sole J; Ugiliweneza B; Johnson E; Burton E; Woo SY; Koutourousiou M; Williams B; Boakye M; Skirboll S
World Neurosurg; 2018 May; 113():e179-e189. PubMed ID: 29427817
[TBL] [Abstract][Full Text] [Related]
37. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
38. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
40. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
Jaeckle KA; Ballman K; Furth A; Buckner JC
Neurology; 2009 Oct; 73(15):1207-13. PubMed ID: 19822870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]